VibroSense Dynamic’s patents have been approved in India

VibroSense Dynamic’s patent application in India has been approved. The patent protects a significant part of the instrument's accuracy and precision. The company thus has patents in India, China, Japan and Sweden.

The patent protects technology to monitor the static skin pressure, i.e. how hard a patient presses his foot or finger on the vibrating rod, during an examination. The pressure is a very important factor to get reliable and reproducible examination results. This technology is part of what makes VibroSense Dynamic’s instruments unique and superior to competing methods.

In addition to the approved patents the company has pending patent applications in the European Union and Brazil.

The VibroSense Meter device includes additional proprietary technology, in addition to the patented technology, to secure the measurement result, for example, monitoring of the skin temperature and vibrating intensity rate.

Moreover, the company have exclusive rights to all age-matched reference data against which all measurements are compared. The company consistently require Non-Disclosure agreements with all subcontracted third parties that participate in the development of the company's technology.

- India may become a valuable market for VibroSense Dynamics. The incidence of diabetes is widespread in India. An estimated 8.5 % of the population in India suffers from diabetes and the World Diabetes Foundation carries out projects aimed at reducing the number of foot ulcers and amputations in the country. In addition, our device can be used for diagnosis of leprosy which still is widespread in India, says Toni Speidel, CEO VibroSense Dynamics AB.

Toni Speidel, CEO, VibroSense Dynamics AB, +46 40 650 14 12,,

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in the legs and arms.

The Company, founded in 2005, is listed on the Small Cap list AktieTorget since May 2015. The product portfolio includes a CE-marked medical device, the VibroSense Meter, for diagnostics of impaired sensitivity in the hands.

About Us

VibroSense Dynamics AB (public) sells and develops efficient systems to support early detection and diagnosis of sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in e.g. legs and arms. The Company, founded in 2005, has been listed on Spotlight stock market since May 2015. Our vision is that the VibroSense Meter shall be the golden standard instrument for neurological examinations to assess sensory neuropathy and help to improve life conditions for patients having a risk of getting nerve injuries.


Documents & Links